Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

KOL Strategy

- PMLiVE

Novartis UK launches local charity partnerships to support social mobility pledges

The company has partnered with the Social Mobility Foundation, Founders4Schools and OnSide

- PMLiVE

Lessons from a pandemic – holistic strategy in the time of coronavirus

COVID-19 has delivered a scenario where developing the strategy for any brand is a challenge

- PMLiVE

Is there such a thing as the new normal? Or is it simply the ‘here and now’?

By Chris Grimes-Crompton

The decentralisation of clinical trials is a key catalyst for innovation in artificial intelligence

By Michael Phillips

- PMLiVE

The great reset of frontline HCP relationships

By Madelaine Allen

- PMLiVE

Equipping our people leaders to drive an inclusive organisation

By Mary O’Reilly (pictured) and Nikki O’Hanlon

- PMLiVE

Listen, learn and lift off

By Danny Buckland

- PMLiVE

Virtually present: how to hear every voice in a hybrid setting

By Shaun Beedle

- PMLiVE

Let them eat peanut butter on toast – why HCPs value familiarity over something new

By Kirsty Mead

- PMLiVE

Sanofi’s Rezurock results show positive patient outcomes

Pooled analysis of chronic graft-versus-host disease treatment demonstrates organ clinical responses correlated with meaningful changes

regeneron headquarters

Regeneron set to acquire Checkmate for approximately $250m

The deal is expected to be finalised in mid-2022

- PMLiVE

Sanofi begins construction on the first of two Evolutive Vaccine Facilities in Singapore

The two sites aim to improve pandemic preparedness and will have an estimated cost of $1.3bn over the next five years

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links